These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 19581844)

  • 1. Divergent oncogenic changes influence survival differences between colon and rectal adenocarcinomas.
    Kalady MF; Sanchez JA; Manilich E; Hammel J; Casey G; Church JM
    Dis Colon Rectum; 2009 Jun; 52(6):1039-45. PubMed ID: 19581844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis.
    Kalady MF; Dejulius KL; Sanchez JA; Jarrar A; Liu X; Manilich E; Skacel M; Church JM
    Dis Colon Rectum; 2012 Feb; 55(2):128-33. PubMed ID: 22228154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and molecular diversity of colon cancer hepatic metastases.
    Messick CA; Sanchez J; Dejulius KL; Church JM; Kalady MF
    Surgery; 2009 Aug; 146(2):227-31. PubMed ID: 19628078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage III & IV colon and rectal cancers share a similar genetic profile: a review of the Oregon Colorectal Cancer Registry.
    Gawlick U; Lu KC; Douthit MA; Diggs BS; Schuff KG; Herzig DO; Tsikitis VL
    Am J Surg; 2013 May; 205(5):608-12; discussion 612. PubMed ID: 23592171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features.
    Pai RK; Jayachandran P; Koong AC; Chang DT; Kwok S; Ma L; Arber DA; Balise RR; Tubbs RR; Shadrach B; Pai RK
    Am J Surg Pathol; 2012 May; 36(5):744-52. PubMed ID: 22314188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer.
    Kohonen-Corish MR; Tseung J; Chan C; Currey N; Dent OF; Clarke S; Bokey L; Chapuis PH
    Int J Cancer; 2014 Jun; 134(12):2820-8. PubMed ID: 24259266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CIMP status of interval colon cancers: another piece to the puzzle.
    Arain MA; Sawhney M; Sheikh S; Anway R; Thyagarajan B; Bond JH; Shaukat A
    Am J Gastroenterol; 2010 May; 105(5):1189-95. PubMed ID: 20010923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the methylator (serrated) colorectal cancer phenotype through precursor serrated polyps.
    Messick CA; Church J; Casey G; Kalady MF
    Dis Colon Rectum; 2009 Sep; 52(9):1535-41. PubMed ID: 19690479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metachronous serrated neoplasia is uncommon after right colectomy in patients with methylator colon cancers with a high degree of microsatellite instability.
    Messick CA; Kravochuck S; Church JM; Kalady MF
    Dis Colon Rectum; 2014 Jan; 57(1):39-46. PubMed ID: 24316944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic and molecular characteristics of synchronous colorectal cancers: heterogeneity of clinical outcome depending on microsatellite instability status of individual tumors.
    Bae JM; Cho NY; Kim TY; Kang GH
    Dis Colon Rectum; 2012 Feb; 55(2):181-90. PubMed ID: 22228162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases.
    Barault L; Charon-Barra C; Jooste V; de la Vega MF; Martin L; Roignot P; Rat P; Bouvier AM; Laurent-Puig P; Faivre J; Chapusot C; Piard F
    Cancer Res; 2008 Oct; 68(20):8541-6. PubMed ID: 18922929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer.
    Hong SP; Min BS; Kim TI; Cheon JH; Kim NK; Kim H; Kim WH
    Eur J Cancer; 2012 May; 48(8):1235-43. PubMed ID: 22071131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel case of rhabdoid colon carcinoma associated with a positive CpG island methylator phenotype and BRAF mutation.
    Pancione M; Di Blasi A; Sabatino L; Fucci A; Dalena AM; Palombi N; Carotenuto P; Aquino G; Daniele B; Normanno N; Colantuoni V
    Hum Pathol; 2011 Jul; 42(7):1047-52. PubMed ID: 21315413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the CpG island methylator phenotype in colorectal cancer prognosis depends on microsatellite instability screening status.
    Dahlin AM; Palmqvist R; Henriksson ML; Jacobsson M; Eklöf V; Rutegård J; Oberg A; Van Guelpen BR
    Clin Cancer Res; 2010 Mar; 16(6):1845-55. PubMed ID: 20197478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CpG island methylator phenotype infers a poor disease-free survival in locally advanced rectal cancer.
    Jo P; Jung K; Grade M; Conradi LC; Wolff HA; Kitz J; Becker H; Rüschoff J; Hartmann A; Beissbarth T; Müller-Dornieden A; Ghadimi M; Schneider-Stock R; Gaedcke J
    Surgery; 2012 Apr; 151(4):564-70. PubMed ID: 22001634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor LINE-1 methylation level and colorectal cancer location in relation to patient survival.
    Mima K; Nowak JA; Qian ZR; Cao Y; Song M; Masugi Y; Shi Y; da Silva A; Gu M; Li W; Hamada T; Zhang X; Wu K; Meyerhardt JA; Baba H; Giovannucci EL; Chan AT; Fuchs CS; Ogino S; Nishihara R
    Oncotarget; 2016 Aug; 7(34):55098-55109. PubMed ID: 27391152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of anatomical subsite on the incidence of microsatellite instability, and KRAS and BRAF mutation rates in patients with colon carcinoma.
    Benedix F; Meyer F; Kube R; Kropf S; Kuester D; Lippert H; Roessner A; Krüger S
    Pathol Res Pract; 2012 Oct; 208(10):592-7. PubMed ID: 22898351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.
    Goel A; Nagasaka T; Arnold CN; Inoue T; Hamilton C; Niedzwiecki D; Compton C; Mayer RJ; Goldberg R; Bertagnolli MM; Boland CR
    Gastroenterology; 2007 Jan; 132(1):127-38. PubMed ID: 17087942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of colon and rectal somatic DNA alterations.
    Slattery ML; Curtin K; Wolff RK; Boucher KM; Sweeney C; Edwards S; Caan BJ; Samowitz W
    Dis Colon Rectum; 2009 Jul; 52(7):1304-11. PubMed ID: 19571709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct genetic and epigenetic signatures of colorectal cancers according to ethnic origin.
    Nieminen TT; Shoman S; Eissa S; Peltomäki P; Abdel-Rahman WM
    Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):202-11. PubMed ID: 22028395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.